Above all these resistance mechanisms, classical multidrug resistance (MDR) mediated via trans-membrane transporters like MRP-1 and LRP contribute to foremost resistance mechanism against various anticancer drugs in retinoblastoma. Here, ABCC1 is linked to retinoblastoma.